CoChat
Sign Up
Cited by 2,778Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionCancer Risks and Factors

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Global Patterns of Cancer Incidence and Mortality Rates and Trends

Open access
Jemal, Ahmedin, Center, Melissa M., DeSantis, Carol, Ward, Elizabeth M.·2010·Cancer Epidemiology, Biomarkers & Prevention
DOI 10.1158/1055-9965.epi-10-0437

Published version of a preprint

Open this paper in CoChat — free accountOpen PDF

Abstract

While incidence and mortality rates for most cancers (including lung, colorectum, female breast, and prostate) are decreasing in the United States and many other western countries, they are increasing in several less developed and economically transitioning countries because of adoption of unhealthy western lifestyles such as smoking and physical inactivity and consumption of calorie-dense food. Indeed, the rates for lung and colon cancers in a few of these countries have already surpassed those in the United States and other western countries. Most developing countries also continue to be disproportionately affected by cancers related to infectious agents, such as cervix, liver, and stomach cancers. The proportion of new cancer cases diagnosed in less developed countries is projected to increase from about 56% of the world total in 2008 to more than 60% in 2030 because of the increasing trends in cancer rates and expected increases in life expectancy and growth of the population. In this review, we describe these changing global incidence and mortality patterns for select common cancers and the opportunities for cancer prevention in developing countries. Cancer Epidemiol Biomarkers Prev; 19(8); 1893–907. ©2010 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-10-0437

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prevention measures in the form of screening and vaccination are effective as well as cost-effective in reducing the burden of cervical cancer, as shown by experience from developed countries.

    “Experience from developed countries has shown that prevention measures in the form of screening and vaccination is effective as well as cost-effective in reducing the burden of cervical cancer. [5]”

    From Cost effectiveness of strategies for cervical cancer prevention in India (2020) · cites this paper as [5]

    The Cervix uteri section reports that cervical cancer rates fell by as much as 65% in several Western countries with long-established screening programs. It describes HPV vaccination as an opportunity to reduce the future burden, not as a demonstrated result of developed-country experience. It calls some screening methods affordable but does not establish that screening and vaccination are both cost-effective; it notes the vaccine’s high cost. Page numbers were not provided in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 172

  1. Kolonel, 2006, Migrant studies, 189, 10.1093/acprof:oso/9780195149616.003.0011 · DOI
  2. Buell, 1965, Cancer mortality among Japanese Issei and Nisei of California, Cancer, 18, 656, 10.1002/1097-0142(196505)18:5<656::AID-CNCR2820180515>3.0.CO;2-3 · DOI
  3. Shafey, 2003, Tobacco control country profiles
  4. Popkin, 2006, Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases, Am J Clin Nutr, 84, 289, 10.1093/ajcn/84.2.289 · DOI · Paper page
  5. World Health Organization, 2008, World cancer report 2008, 10.30875/e89f8212-en · DOI
  6. Kanavos, 2006, The rising burden of cancer in the developing world, Ann Oncol, 17, viii15, 10.1093/annonc/mdl983 · DOI
  7. Center, 2009, Worldwide variations in colorectal cancer, CA Cancer J Clin, 59, 366, 10.3322/caac.20038 · DOI
  8. American Cancer Society, 2007, Global cancer facts & figures 2007
  9. Thun, 2010, The global burden of cancer: priorities for prevention, Carcinogenesis, 31, 100, 10.1093/carcin/bgp263 · DOI
  10. Ferlay, 2010, GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]
  11. World Health Organization, 2007, Ten statistical highlights in global public health
  12. Anderson, 1998, Age standardization of death rates: implementation of the year 2000 standard, Natl Vital Stat Rep, 47, 1
  13. Jemal, 2005, Cancer statistics, 226
  14. Youlden, 2008, The international epidemiology of lung cancer: geographical distribution and secular trends, J Thorac Oncol, 3, 819, 10.1097/JTO.0b013e31818020eb · DOI
  15. Bray, 2010, Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007, Int J Cancer, 126, 1454, 10.1002/ijc.24855 · DOI
  16. Ezzati, 2005, Role of smoking in global and regional cancer epidemiology: current patterns and data needs, Int J Cancer, 116, 963, 10.1002/ijc.21100 · DOI
  17. Ezzati, 2003, Estimates of global mortality attributable to smoking in 2000, Lancet, 362, 847, 10.1016/S0140-6736(03)14338-3 · DOI · Paper page
  18. Peto, 2006, Mortality from smoking in developed countries 1950-2000
  19. Jemal, 2008, Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control, J Natl Cancer Inst, 100, 1672, 10.1093/jnci/djn389 · DOI
  20. Lam, 2004, Lung cancer epidemiology and risk factors in Asia and Africa, Int J Tuberc Lung Dis, 8, 1045
  21. Glynn, 2010, The globalization of tobacco use: 21 challenges for the 21st century, CA Cancer J Clin, 60, 50, 10.3322/caac.20052 · DOI
  22. Yach, 2005, Improving diet and physical activity: 12 lessons from controlling tobacco smoking, BMJ, 330, 898, 10.1136/bmj.330.7496.898 · DOI
  23. Hafez, 2005, How Philip Morris built Marlboro into a global brand for young adults: implications for international tobacco control, Tob Control, 14, 262, 10.1136/tc.2005.011189 · DOI
  24. Warner, 2006, The global tobacco disease pandemic: nature, causes, and cures, Glob Public Health, 1, 65, 10.1080/17441690500430771 · DOI
  25. Centers for Disease Control and Prevention, 2007, Best practices for comprehensive tobacco control programs—2007
  26. Spitz, 2006, Cancer of the lung
  27. Mackay, 2006, The tobacco atlas
  28. Boffetta, 2003, Contribution of environmental factors to cancer risk, Br Med Bull, 68, 71, 10.1093/bmp/ldg023 · DOI
  29. Thun, 2008, Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies, PLoS MEd, 5, e185, 10.1371/journal.pmed.0050185 · DOI
  30. Center, 2009, International trends in colorectal cancer incidence rates, Cancer Epidemiol Biomarkers Prev, 18, 1688, 10.1158/1055-9965.EPI-09-0090 · DOI
  31. Garcia-Alvarez, 2007, Obesity and overweight trends in Catalonia, Spain (1992-2003): gender and socio-economic determinants, Public Health Nutr, 10, 1368, 10.1017/S1368980007000973 · DOI
  32. Martin, 2008, Trends in childhood and adolescent obesity prevalence in Oviedo (Asturias, Spain) 1992-2006, Acta Paediatr, 97, 955, 10.1111/j.1651-2227.2008.00828.x · DOI
  33. de Kok, 2008, Gender differences in the trend of colorectal cancer incidence in Singapore, 1968-2002, Int J Colorectal Dis, 23, 461, 10.1007/s00384-007-0421-9 · DOI
  34. Berghofer, 2008, Obesity prevalence from a European perspective: a systematic review, BMC Public Health, 8, 200, 10.1186/1471-2458-8-200 · DOI
  35. Edwards, 2010, Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates, Cancer, 116, 544, 10.1002/cncr.24760 · DOI · Paper page
  36. Chu, 1994, Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990, J Natl Cancer Inst, 86, 997, 10.1093/jnci/86.13.997 · DOI
  37. Mitry, 2002, Benefit of operative mortality reduction on colorectal cancer survival, Br J Surg, 89, 1557, 10.1046/j.1365-2168.2002.02276.x · DOI
  38. Sant, 2001, Cancer survival increases in Europe, but international differences remain wide, Eur J Cancer, 2001, 1659, 10.1016/S0959-8049(01)00206-4 · DOI
  39. Sankaranarayanan, 1999, Cancer survival in developing countries
  40. Sankaranarayanan, 2009, Cancer survival in Africa, Asia, and Central America: a population-based study, Lancet Oncol, 11, 110
  41. Coleman, 2008, Cancer survival in five continents: a worldwide population-based study (CONCORD), Lancet Oncol, 9, 730, 10.1016/S1470-2045(08)70179-7 · DOI · Paper page
  42. Sant, 2009, EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary, Eur J Cancer, 45, 931, 10.1016/j.ejca.2008.11.018 · DOI
  43. Mandel, 1993, Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study, N Engl J Med, 328, 1365, 10.1056/NEJM199305133281901 · DOI
  44. Zauber, 2008, Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force, Ann Intern Med, 149, 659, 10.7326/0003-4819-149-9-200811040-00244 · DOI
  45. Muller, 1995, Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans, Ann Intern Med, 123, 904, 10.7326/0003-4819-123-12-199512150-00002 · DOI
  46. Benson, 2008, Colorectal cancer screening: a comparison of 35 initiatives in 17 countries, Int J Cancer, 122, 1357, 10.1002/ijc.23273 · DOI
  47. Parkin, 2006, Use of statistics to assess the global burden of breast cancer, Breast J, 12, S70, 10.1111/j.1075-122X.2006.00205.x · DOI
  48. Zahl, 2008, The natural history of invasive breast cancers detected by screening mammography, Arch Intern Med, 168, 2311, 10.1001/archinte.168.21.2311 · DOI
  49. Roa, 1996, Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2, Nat Genet, 14, 185, 10.1038/ng1096-185 · DOI
  50. American Cancer Society, 2009, Breast cancer facts & figures 2009-2010
  51. Ravdin, 2007, The decrease in breast-cancer incidence in 2003 in the United States, N Engl J Med, 356, 1670, 10.1056/NEJMsr070105 · DOI
  52. Cronin, 2009, Sustained lower rates of breast cancer in the United States, Breast Cancer Res Treat, 117, 223, 10.1007/s10549-008-0226-8 · DOI
  53. Glass, 2007, Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status, J Natl Cancer Inst, 99, 1152, 10.1093/jnci/djm059 · DOI
  54. Breen, 2007, Reported drop in mammography: is this cause for concern?, Cancer, 109, 2405, 10.1002/cncr.22723 · DOI · Paper page
  55. Jemal, 2007, Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women, Breast Cancer Res, 9, R28, 10.1186/bcr1672 · DOI
  56. Pelucchi, 2010, The rise and fall in menopausal hormone therapy and breast cancer incidence, Breast, 19, 198, 10.1016/j.breast.2010.01.021 · DOI
  57. Parkin, 2009, Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?, Eur J Cancer, 45, 1649, 10.1016/j.ejca.2009.01.016 · DOI
  58. Seradour, 2009, Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006, Bull Cancer, 96, E1
  59. Canfell, 2008, Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia, Med J Aust, 188, 641, 10.5694/j.1326-5377.2008.tb01821.x · DOI
  60. Althuis, 2005, Global trends in breast cancer incidence and mortality 1973-1997, Int J Epidemiol, 34, 405, 10.1093/ije/dyh414 · DOI
  61. Berry, 2005, Effect of screening and adjuvant therapy on mortality from breast cancer, N Engl J Med, 353, 1784, 10.1056/NEJMoa050518 · DOI
  62. Levi, 2005, Monitoring the decrease in breast cancer mortality in Europe, Eur J Cancer Prev, 14, 497, 10.1097/00008469-200512000-00002 · DOI
  63. Sant, 2006, Time trends of breast cancer survival in Europe in relation to incidence and mortality, Int J Cancer, 119, 2417, 10.1002/ijc.22160 · DOI
  64. Freitas-Junior, 2008, Variations in breast cancer incidence per decade of life (Goiania, GO, Brazil): 16-year analysis, Cancer Causes Control, 19, 681, 10.1007/s10552-008-9131-z · DOI
  65. Takiar, 2008, Time trend in breast and cervix cancer of women in India (1990-2003), Asian Pac J Cancer Prev, 9, 777
  66. Bosetti, 2005, Trends in cancer mortality in the Americas, 1970-2000, Ann Oncol, 16, 489, 10.1093/annonc/mdi086 · DOI
  67. Parkin, 2010, Changing cancer incidence in Kampala, Uganda, 1991-2006, Int J Cancer, 126, 1187, 10.1002/ijc.24838 · DOI
  68. Prentice, 2006, The emerging epidemic of obesity in developing countries, Int J Epidemiol, 35, 93, 10.1093/ije/dyi272 · DOI
  69. Colditz, 2006, Epidemiology—identifying the causes and preventability of cancer?, Nat Rev, 6, 75, 10.1038/nrc1784 · DOI
  70. Prentice, 2009, Obesity in emerging nations: evolutionary origins and the impact of a rapid nutrition transition, Nestle Nutr Workshop Ser Pediatr Program, 63, 47, 10.1159/000209972 · DOI
  71. Anderson, 2006, Breast cancer in limited-resource countries: health care systems and public policy, Breast J, 12, S54, 10.1111/j.1075-122X.2006.00203.x · DOI
  72. Anderson, 2008, Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007, Cancer, 113, 2221, 10.1002/cncr.23844 · DOI
  73. Hsing, 2000, International trends and patterns of prostate cancer incidence and mortality, Int J Cancer, 85, 60, 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B · DOI
  74. Baade, 2009, International epidemiology of prostate cancer: geographical distribution and secular trends, Mol Nutr Food Res, 53, 171, 10.1002/mnfr.200700511 · DOI
  75. Quinn, 2002, Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons, BJU Int, 90, 162, 10.1046/j.1464-410X.2002.2822.x · DOI
  76. Draisma, 2009, Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context, J Natl Cancer Inst, 101, 374, 10.1093/jnci/djp001 · DOI
  77. Etzioni, 2002, Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends, J Natl Cancer Inst, 94, 981, 10.1093/jnci/94.13.981 · DOI
  78. Armstrong, 1975, Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices, Int J Cancer, 15, 617, 10.1002/ijc.2910150411 · DOI
  79. Rose, 1986, International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption, Cancer, 58, 2363, 10.1002/1097-0142(19861201)58:11<2363::AID-CNCR2820581102>3.0.CO;2-# · DOI
  80. Hayes, 1999, Dietary factors and risks for prostate cancer among blacks and whites in the United States, Cancer Epidemiol Biomarkers Prev, 8, 25
  81. Whittemore, 1995, Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada, J Natl Cancer Inst, 87, 652, 10.1093/jnci/87.9.652 · DOI
  82. Glover, 1998, The epidemiology of prostate cancer in Jamaica, J Urol, 159, 1984, 10.1016/S0022-5347(01)63220-8 · DOI
  83. Bunker, 2002, High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey, Cancer Epidemiol Biomarkers Prev, 11, 726
  84. Bock, 2009, Results from a prostate cancer admixture mapping study in African-American men, Hum Genet, 126, 637, 10.1007/s00439-009-0712-z · DOI
  85. Miller, 2003, Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men, Cancer Res, 63, 3486
  86. Collin, 2008, Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study, Lancet Oncol, 9, 445, 10.1016/S1470-2045(08)70104-9 · DOI
  87. Etzioni, 2008, Quantifying the role of PSA screening in the US prostate cancer mortality decline, Cancer Causes Control, 19, 175, 10.1007/s10552-007-9083-8 · DOI
  88. Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696 · DOI
  89. Schroder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084 · DOI
  90. Parkin, 2006, The global health burden of infection-associated cancers in the year 2002, Int J Cancer, 118, 3030, 10.1002/ijc.21731 · DOI
  91. Vol. 83 (2002). Available from: http://monographs.iarc.fr/ENG/Monographs/vol83/volume83.pdf.
  92. Joossens, 1996, Dietary salt, nitrate and stomach cancer mortality in 24 countries, Int J Epidemiol, 25, 494, 10.1093/ije/25.3.494 · DOI
  93. Bertuccio, 2009, Recent patterns in gastric cancer: a global overview, Int J Cancer, 125, 666, 10.1002/ijc.24290 · DOI
  94. Botterweck, 2000, Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries, Int J Epidemiol, 29, 645, 10.1093/ije/29.4.645 · DOI
  95. Devesa, 1998, Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer, 83, 2049, 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2 · DOI
  96. El-Serag, 2007, Time trends of gastroesophageal reflux disease: a systematic review, Clin Gastroenterol Hepatol, 5, 17, 10.1016/j.cgh.2006.09.016 · DOI
  97. Blot, 1991, Rising incidence of adenocarcinoma of the esophagus and gastric cardia, JAMA, 265, 1287, 10.1001/jama.1991.03460100089030 · DOI
  98. Shibata, 2006, Stomach cancer, 707, 10.1093/acprof:oso/9780195149616.003.0037 · DOI
  99. Hamashima, 2008, The Japanese guidelines for gastric cancer screening, Jpn J Clin Oncol, 38, 259, 10.1093/jjco/hyn017 · DOI
  100. Yoo, 2008, Cancer control activities in the Republic of Korea, Jpn J Clin Oncol, 38, 327, 10.1093/jjco/hyn026 · DOI
  101. Fock, 2008, Asia-Pacific consensus guidelines on gastric cancer prevention, J Gastroenterol Hepatol, 23, 351, 10.1111/j.1440-1746.2008.05314.x · DOI
  102. Meyer, 2002, Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999, Ann Intern Med, 136, 13, 10.7326/0003-4819-136-1-200201010-00008 · DOI
  103. Perz, 2006, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, J Hepatol, 45, 529, 10.1016/j.jhep.2006.05.013 · DOI · Paper page
  104. Bosch, 2004, Primary liver cancer: worldwide incidence and trends, Gastroenterol, 127, s5, 10.1053/j.gastro.2004.09.011 · DOI
  105. Raza, 2007, Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review, Br J Cancer, 96, 1127, 10.1038/sj.bjc.6603649 · DOI
  106. Seeff, 2006, Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity, Oncogene, 25, 3771, 10.1038/sj.onc.1209560 · DOI
  107. Chuang, 2009, Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection, Cancer Lett, 286, 9, 10.1016/j.canlet.2008.10.040 · DOI
  108. McQuillan, 1999, Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994, Am J Public Health, 89, 14, 10.2105/AJPH.89.1.14 · DOI
  109. Blakely, 1999, Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand, Int J Epidemiol, 28, 204, 10.1093/ije/28.2.204 · DOI
  110. Kao, 2005, Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia, Liver Int, 25, 696, 10.1111/j.1478-3231.2005.01139.x · DOI
  111. Percy, 1990, The accuracy of liver cancer as the underlying cause of death on death certificates, Public Health Rep, 105, 361
  112. Bosetti, 2008, Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004, Hepatology, 48, 137, 10.1002/hep.22312 · DOI
  113. La Vecchia, 2009, Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975, Ann Oncol, 21, 1323, 10.1093/annonc/mdp530 · DOI
  114. McGlynn, 2001, International trends and patterns of primary liver cancer, Int J Cancer, 94, 290, 10.1002/ijc.1456 · DOI
  115. Parkin, 2006, International patterns of cancer incidence and mortality, 101, 10.1093/acprof:oso/9780195149616.003.0008 · DOI
  116. Chang, 2009, Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study, J Natl Cancer Inst, 101, 1348, 10.1093/jnci/djp288 · DOI
  117. Chang, 1997, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602 · DOI · Paper page
  118. Shariff, 2009, Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics, Expert Rev Gastroenterol Hepatol, 3, 353, 10.1586/egh.09.35 · DOI
  119. Yoshizawa, 2002, Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future, Oncology, 62, 8, 10.1159/000048270 · DOI
  120. Taylor-Robinson, 1997, Increase in primary liver cancer in the UK, 1979-94, Lancet, 350, 1142, 10.1016/S0140-6736(05)63789-0 · DOI
  121. Wasley, 2000, Epidemiology of hepatitis C: geographic differences and temporal trends, Semin Liver Dis, 20, 1, 10.1055/s-2000-9506 · DOI
  122. Altekruse, 2009, Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005, J Clin Oncol, 27, 1485, 10.1200/JCO.2008.20.7753 · DOI
  123. El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001 · DOI
  124. El-Serag, 2007, Epidemiology of hepatocellular carcinoma in USA, Hepatol Res, 37 Suppl 2, S88, 10.1111/j.1872-034X.2007.00168.x · DOI
  125. El-Serag, 2000, Risk factors for the rising rates of primary liver cancer in the United States, Arch Intern Med, 160, 3227, 10.1001/archinte.160.21.3227 · DOI
  126. World Health Organization, 2004, Weekly epidemiologic record, Hepatitis B Vaccines, 79, 253
  127. Fritz, 2000, International classification of diseases for oncology
  128. Bosetti, 2008, Trends in oesophageal cancer incidence and mortality in Europe, Int J Cancer, 122, 1118, 10.1002/ijc.23232 · DOI
  129. Hongo, 2009, Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity, J Gastroenterol Hepatol, 24, 729, 10.1111/j.1440-1746.2009.05824.x · DOI
  130. Corley, 2001, Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database, Int J Epidemiol, 30, 1415, 10.1093/ije/30.6.1415 · DOI
  131. Gholipour, 2008, A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003, Dis Esophagus, 21, 322, 10.1111/j.1442-2050.2007.00776.x · DOI
  132. Islami, 2004, Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran, Br J Cancer, 90, 1402, 10.1038/sj.bjc.6601737 · DOI
  133. Tran, 2005, Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China, Int J Cancer, 113, 456, 10.1002/ijc.20616 · DOI
  134. Engel, 2003, Population attributable risks of esophageal and gastric cancers, J Natl Cancer Inst, 95, 1404, 10.1093/jnci/djg047 · DOI
  135. Kamangar, 2009, Environmental causes of esophageal cancer, Gastroenterol Clin North Am, 38, 27, 10.1016/j.gtc.2009.01.004 · DOI
  136. Nasrollahzadeh, 2008, Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran, Br J Cancer, 98, 1857, 10.1038/sj.bjc.6604369 · DOI
  137. Pourshams, 2005, Golestan cohort study of oesophageal cancer: feasibility and first results, Br J Cancer, 92, 176, 10.1038/sj.bjc.6602249 · DOI
  138. Hakami, 2008, Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran, Nutr Cancer, 60, 216, 10.1080/01635580701684831 · DOI
  139. Islami, 2009, High-temperature beverages and foods and esophageal cancer risk—a systematic review, Int J Cancer, 125, 491, 10.1002/ijc.24445 · DOI · Paper page
  140. Islami, 2009, Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran—a review, Eur J Cancer, 45, 3156, 10.1016/j.ejca.2009.09.018 · DOI
  141. Fan, 2008, Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study, Nutr Cancer, 60, 354, 10.1080/01635580701883011 · DOI
  142. Cook, 2009, Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005, Br J Cancer, 101, 855, 10.1038/sj.bjc.6605246 · DOI
  143. Lu, 2010, Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan, Cancer Causes Control, 21, 269, 10.1007/s10552-009-9458-0 · DOI
  144. Lepage, 2008, Continuing rapid increase in esophageal adenocarcinoma in England and Wales, Am J Gastroenterol, 103, 2694, 10.1111/j.1572-0241.2008.02191.x · DOI
  145. Post, 2007, Rising incidence of clinically evident Barrett's oesophagus in the Netherlands: a nation-wide registry of pathology reports, Scand J Gastroenterol, 42, 17, 10.1080/00365520600815654 · DOI
  146. Islami, 2008, Helicobacter pylori and esophageal cancer risk: a meta-analysis, Cancer Prev Res, 1, 329, 10.1158/1940-6207.CAPR-08-0109 · DOI
  147. Rokkas, 2007, Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis, Clin Gastroenterol Hepatol, 5, 1413, 10.1016/j.cgh.2007.08.010 · DOI
  148. Yeh, 2009, Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections, Cancer Causes Control, 20, 2021, 10.1007/s10552-009-9397-9 · DOI
  149. Vizcaino, 2002, Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995, Int J Cancer, 99, 860, 10.1002/ijc.10427 · DOI
  150. Yang, 2004, Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost, Int J Cancer, 109, 418, 10.1002/ijc.11719 · DOI
  151. Castellsague, 2006, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention, J Natl Cancer Inst, 5, 303, 10.1093/jnci/djj067 · DOI
  152. International Collaboration of Epidemiological Studies of Cervical Cancer, 2009, Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies, Cancer Epidemiol Biomarkers Prev, 18, 1060, 10.1158/1055-9965.EPI-08-1186 · DOI
  153. Schiffman, 2006, Cervical cancer, 1044, 10.1093/acprof:oso/9780195149616.003.0054 · DOI
  154. Maucort-Boulch, 2008, International correlation between human papillomavirus prevalence and cervical cancer incidence, Cancer Epidemiol Biomarkers Prev, 17, 717, 10.1158/1055-9965.EPI-07-2691 · DOI
  155. Bray, 2005, Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening, Cancer Epidemiol Biomarkers Prev, 14, 677, 10.1158/1055-9965.EPI-04-0569 · DOI · Paper page
  156. Parkin, 2008, Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region, Vaccine, 26 Suppl 11, L1, 10.1016/j.vaccine.2008.05.043 · DOI
  157. Mathew, 2009, Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix—worldwide, Asian Pac J Cancer Prev, 10, 645
  158. Vizcaino, 2000, International trends in incidence of cervical cancer: II. Squamous-cell carcinoma, Int J Cancer, 86, 429, 10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D · DOI
  159. Chung, 2006, Cervical cancer incidence and survival in Korea: 1993-2002, Int J Gynecol Cancer, 16, 1833, 10.1111/j.1525-1438.2006.00708.x · DOI
  160. Yang, 2004, Estimation and projection of the national profile of cancer mortality in China: 1991-2005, Br J Cancer, 90, 2157, 10.1038/sj.bjc.6601813 · DOI
  161. Chen, 2009, Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences, Br J Cancer, 101, 174, 10.1038/sj.bjc.6605139 · DOI
  162. Anttila, 1999, Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence, Int J Cancer, 83, 59, 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N · DOI
  163. Gustafsson, 1997, International incidence rates of invasive cervical cancer before cytological screening, Int J Cancer, 71, 159, 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-# · DOI
  164. Sherris, 2009, Evidence-based, alternative cervical cancer screening approaches in low-resource settings, Int Perspect Sex Reprod Health, 35, 147, 10.1363/3514709 · DOI
  165. Arbyn, 2008, Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India, Int J Cancer, 123, 153, 10.1002/ijc.23489 · DOI
  166. Sankaranarayanan, 2009, HPV screening for cervical cancer in rural India, N Engl J Med, 360, 1385, 10.1056/NEJMoa0808516 · DOI · Paper page
  167. Sankaranarayanan, 2009, HPV vaccination: the promise & problems, Indian J Med Res, 130, 322
  168. Yadav, 2008, Changing patterns of diet, physical activity and obesity among urban, rural and slum populations in north India, Obes Rev, 9, 400, 10.1111/j.1467-789X.2008.00505.x · DOI
  169. World Health Organization, 2002, National cancer control programmes: policies and managerial guidelines
  170. World Health Organization, 2009, 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases: prevent and control cardiovascular diseases, cancers, chronic respiratory diseases and diabetes
  171. Ngoma, 2006, World Health Organization cancer priorities in developing countries, Ann Oncol, 17, viii9, 10.1093/annonc/mdl982 · DOI
  172. Boyle, 2008, Need for global action for cancer control, Ann Oncol, 19, 1519, 10.1093/annonc/mdn426 · DOI

Cited by

Sorted by citations

Metadata

Authors
Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M.
Affiliations
  • American Cancer Society (US)
  • Authors' Affiliation: Surveillance and Health Policy Research Department, American Cancer Society, Atlanta, Georgia
Corresponding author
Jemal, Ahmedin
ORCID
Venue
Cancer Epidemiology, Biomarkers & Prevention
Publisher
American Association for Cancer Research (AACR)
Published
2010-08-01
Volume
19
Issue
8
Pages
1893-1907
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
DOI
10.1158/1055-9965.epi-10-0437
OpenAlex
W2126945850
Cited by
2,778
References
6
Citations by year
2026: 33 · 2025: 73 · 2024: 96 · 2023: 108 · 2022: 130 · 2021: 160 · 2020: 177 · 2019: 166 · 2018: 214 · 2017: 213 · 2016: 267 · 2015: 276 · 2014: 273 · 2013: 250 · 2012: 209
FWCI
20.54
Type
journal article
Language
en
Open access
Locations
  • Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
global cancer incidence, cancer mortality, cancer trends, lung cancer, colorectal cancer, breast cancer, prostate cancer, cervical cancer, liver cancer, gastric cancer, developing countries, cancer prevention, population growth, life expectancy
MeSH terms
Developing Countries, Humans, Mortality, Neoplasms, Global Health, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review